Use and Outcomes of SARS-COV-2 Monoclonal Antibody Therapy in Patients with Primary Immunodeficiency

被引：0
|
作者：
Monahan, Rose [1 ]
Tang, Monica [1 ]
Pham, Michele [1 ]
机构：
[1] UCSF, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL IMMUNOLOGY | 2022年 / 42卷 / SUPPL 1期
关键词：
SARS-CoV-2; Covid-19; monoclonal antibody therapy; REGN-COV2; antibody deficiency;
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
146
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [1] Functionality of Monoclonal Antibody Therapy in SARS-CoV-2
    Ali, Ruhma
    Patel, Aditya
    Waqas, Muhammad A.
    Trivedi, Krunal
    Slim, Jihad
    JOURNAL OF MEDICAL CASES, 2022, 13 (08) : 380 - 385
  • [2] Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response
    Kim, Paul S.
    Dimcheff, Derek E.
    Siler, Andrew
    Schildhouse, Richard J.
    Chensue, Stephen W.
    CLINICAL IMMUNOLOGY, 2022, 236
  • [3] Outcomes following SARS-CoV-2 infection in patients with primary and secondary immunodeficiency in the UK
    Shields, Adrian M.
    Anantharachagan, Ariharan
    Arumugakani, Gururaj
    Baker, Kenneth
    Bahal, Sameer
    Baxendale, Helen
    Bermingham, William
    Bhole, Malini
    Boules, Evon
    Bright, Philip
    Chopra, Charu
    Cliffe, Lucy
    Cleave, Betsy
    Dempster, John
    Devlin, Lisa
    Dhalla, Fatima
    Diwakar, Lavanya
    Drewe, Elizabeth
    Duncan, Christopher
    Dziadzio, Magdalena
    Elcombe, Suzanne
    Elkhalifa, Shuayb
    Gennery, Andrew
    Ghanta, Harichandrana
    Goddard, Sarah
    Grigoriadou, Sofia
    Hackett, Scott
    Hayman, Grant
    Herriot, Richard
    Herwadkar, Archana
    Huissoon, Aarnoud
    Jain, Rashmi
    Jolles, Stephen
    Johnston, Sarah
    Khan, Sujoy
    Laffan, James
    Lane, Peter
    Leeman, Lucy
    Lowe, David M.
    Mahabir, Shanti
    Mac Lochlainn, Dylan James
    McDermott, Elizabeth
    Misbah, Siraj
    Moghaddas, Fiona
    Morsi, Hadeil
    Murng, Sai
    Noorani, Sadia
    O'Brien, Rachael
    Patel, Smita
    Price, Arthur
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2022, 209 (03): : 247 - 258
  • [4] Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
    Manon Ragonnet-Cronin
    Rungtiwa Nutalai
    Jiandong Huo
    Aiste Dijokaite-Guraliuc
    Raksha Das
    Aekkachai Tuekprakhon
    Piyada Supasa
    Chang Liu
    Muneeswaran Selvaraj
    Natalie Groves
    Hassan Hartman
    Nicholas Ellaby
    J. Mark Sutton
    Mohammad W. Bahar
    Daming Zhou
    Elizabeth Fry
    Jingshan Ren
    Colin Brown
    Paul Klenerman
    Susanna J. Dunachie
    Juthathip Mongkolsapaya
    Susan Hopkins
    Meera Chand
    David I. Stuart
    Gavin R. Screaton
    Sakib Rokadiya
    Nature Communications, 14
  • [5] Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
    Ragonnet-Cronin, Manon
    Nutalai, Rungtiwa
    Huo, Jiandong
    Dijokaite-Guraliuc, Aiste
    Das, Raksha
    Tuekprakhon, Aekkachai
    Supasa, Piyada
    Liu, Chang
    Selvaraj, Muneeswaran
    Groves, Natalie
    Hartman, Hassan
    Ellaby, Nicholas
    Sutton, J. Mark
    Bahar, Mohammad W.
    Zhou, Daming
    Fry, Elizabeth
    Ren, Jingshan
    Brown, Colin
    Klenerman, Paul
    Dunachie, Susanna J.
    Mongkolsapaya, Juthathip
    Hopkins, Susan
    Chand, Meera
    Stuart, David I.
    Screaton, Gavin R.
    Rokadiya, Sakib
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [6] Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
    Delavari, Samaneh
    Abolhassani, Hassan
    Abolnezhadian, Farhad
    Babaha, Fateme
    Iranparast, Sara
    Ahanchian, Hamid
    Moazzen, Nasrin
    Nabavi, Mohammad
    Arshi, Saba
    Fallahpour, Morteza
    Bemanian, Mohammad Hassan
    Shokri, Sima
    Momen, Tooba
    Sadeghi-Shabestari, Mahnaz
    Molatefi, Rasol
    Shirkani, Afshin
    Vosughimotlagh, Ahmad
    Safarirad, Molood
    Sharifzadeh, Meisam
    Pashangzadeh, Salar
    Salami, Fereshte
    Shirmast, Paniz
    Rezaei, Arezou
    Shad, Tannaz Moeini
    Mohraz, Minoo
    Rezaei, Nima
    Hammarstrom, Lennart
    Yazdani, Reza
    Aghamohamamdi, Asghar
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (02) : 345 - 355
  • [7] Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
    Samaneh Delavari
    Hassan Abolhassani
    Farhad Abolnezhadian
    Fateme Babaha
    Sara Iranparast
    Hamid Ahanchian
    Nasrin Moazzen
    Mohammad Nabavi
    Saba Arshi
    Morteza Fallahpour
    Mohammad Hassan Bemanian
    Sima Shokri
    Tooba Momen
    Mahnaz Sadeghi-Shabestari
    Rasol Molatefi
    Afshin Shirkani
    Ahmad Vosughimotlagh
    Molood Safarirad
    Meisam Sharifzadeh
    Salar Pashangzadeh
    Fereshte Salami
    Paniz Shirmast
    Arezou Rezaei
    Tannaz Moeini Shad
    Minoo Mohraz
    Nima Rezaei
    Lennart Hammarström
    Reza Yazdani
    Asghar Aghamohamamdi
    Journal of Clinical Immunology, 2021, 41 : 345 - 355
  • [8] Monoclonal antibody therapy in COVID-19 induced by SARS-CoV-2
    Conti, P.
    Pregliasco, F. E.
    Calvisi, V.
    Caraffa, A.
    Gallenga, C. E.
    Kritas, S. K.
    Ronconi, G.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2021, 35 (02): : 423 - 427
  • [9] Durable Protection after Anti?SARS-CoV-2 Monoclonal Antibody Therapy
    Misch, Elizabeth A.
    KIDNEY360, 2022, 3 (01): : 8 - 10
  • [10] Monoclonal antibody therapies against SARS-CoV-2
    Focosi, Daniele
    McConnell, Scott
    Casadevall, Arturo
    Cappello, Emiliano
    Valdiserra, Giulia
    Tuccori, Marco
    LANCET INFECTIOUS DISEASES, 2022, 22 (11): : E311 - E326
12345